🇺🇸 FDA

Intelligence Platform

Patents

Browse 750 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7105156

Method of using an adenoviral vector encoding a retinoblastoma protein to treat hyperproli

The Regents of the University of California · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7101557

Combined tissue factor methods for coagulation and tumor treatment

The Board of Regents of the University of Texas System · Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7098191

Hyperthermic inducible expression vectors for gene therapy and methods of use thereof

THE ARIZONA BOARD OF REGENTS · Granted Tue Aug 29 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7094408

Immunogenicity using a combination of DNA and vaccinia virus vector vaccines

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7087723

Albumin-free factor VIII formulations

UNIVERSITY OF CONNECTICUT · Granted Tue Aug 08 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7078508

Ixodes scapularis tissue factor pathway inhibitor

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 18 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 13 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7056897

Inducible expression vectors and methods of use thereof

THE ARIZONA BOARD OF REGENTS · Granted Tue Jun 06 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7052904

Hybrid adeno-retroviral vector for the transfection of cells

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue May 30 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 25 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7034118

Corticotropin-releasing factor2 receptors

Neurocrine Biosciences, Inc. · Granted Tue Apr 25 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 7026291

Epithelial cell specific growth factor, keratinocyte growth factor (KGF)

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 11 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6998117

Cancer treatment with retroviral vectors comprising wild-type p53

The Board of Regents of the University of Texas System · Granted Tue Feb 14 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6991794

Progenitor cell preservation factors and methods for and products of their use

The Regents of the University of California · Granted Tue Jan 31 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6969609

Recombinant vector expressing multiple costimulatory molecules and uses thereof

The United States of America as represented by the Department of Health and Human Serivces · Granted Tue Nov 29 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6962798

Methods and compositions relating to a cardiac-specific nuclear regulatory factor

The Board of Regents of the University of Texas System · Granted Tue Nov 08 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6953834

Transcription factors related to TFIIA

The Board of Regents of the University of Texas System · Granted Tue Oct 11 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6953575

Methods of treating central nervous system disorders using viral vectors

The Regents of the University of California · Granted Tue Oct 11 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6942855

Viral vectors having reduced virulence

THE ARIZONA BOARD OF REGENTS · Granted Tue Sep 13 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6943153

Use of recombinant gene delivery vectors for treating or preventing diseases of the eye

The Regents of the University of California · Granted Tue Sep 13 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6899882

Endothelial cell growth factor methods of isolation and expression

The Regents of the University of California · Granted Tue May 31 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6867022

Replication deficient adenovirus vectors and methods of making and using them

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Mar 15 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6855314

AAV5 vector for transducing brain cells and lung cells

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 15 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6852321

Lectin-derived progenitor cell preservation factor and methods of use

The Regents of the University of California · Granted Tue Feb 08 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6846652

Viral vectors having enhanced effectiveness with reduced virulence

THE ARIZONA BOARD OF REGENTS · Granted Tue Jan 25 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6846809

PEI: DNA vector formulations for in vitro and in vivo gene delivery

The Board of Regents of the University of Texas System · Granted Tue Jan 25 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired